Breaking News Instant updates and real-time market news.

CRSP

Crispr Therapeutics

$37.21

1.22 (3.39%)

07:12
01/22/19
01/22
07:12
01/22/19
07:12

Citi downgrades Crispr Therapeutics to Sell with $21 price target

Citi analyst Yigal Nochomovitz downgraded Crispr Therapeutics to Sell from Neutral and cut his price target for the shares to $21 from $28. Crispr's near-term valuation driver and lead program in related blood disorders "substantially lags" more advanced competitors, Nochomovitz tells investors in a research note. The analyst believes the company's CTX-001 is "at best equivalent" to more advanced competitors and "could have some important liabilities."

CRSP Crispr Therapeutics
$37.21

1.22 (3.39%)

11/30/18
NEED
11/30/18
INITIATION
Target $62
NEED
Buy
Crispr Therapeutics initiated with a Buy at Needham
Needham analyst Alan Carr initiated CRISPR Therapeutics (CRSP) with a Buy rating and a price target of $62 based on its position as a "leader in gene editing". The analyst notes that the company is "initially focused on ex vivo applications of the technology associated with reduced technical and safety risks", which he believes to hold "substantial value, particularly in immuno-oncology." Carr adds that with Crispr and collaborator Vertex (VRTX) recently launching a clinical development of CTX-001 in Beta Thalassemia and Sickle Cell Disease, he estimates the company to launch these products in the U.S. in 2022 and 2023, respectively.
12/20/18
PIPR
12/20/18
NO CHANGE
Target $75
PIPR
Overweight
Piper Jaffray encouraged by enthusiasm for Crispr Therapeutics' CTX-001
Piper Jaffray analyst Edward Tenthoff kept his Overweight rating and $75 price target, saying his interviews with hematologists indicate that the current standard-of-care hydroxyurea is poorly tolerated and offers "a huge opportunity" for emerging therapies. The analyst states that he is encouraged by "early enthusiasm based on the promise of CRISPR/Cas9 in SCD considering the company has yet to present any clinical data on CTX-001."
01/02/19
PIPR
01/02/19
NO CHANGE
Target $75
PIPR
Overweight
Crispr Therapeutics named a top pick for 2019 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff names Crispr Therapeutics a top pick for 2019 and reiterates an Overweight rating on the shares with a $75 price target. The stock closed the trading day up $1.30 to $29.87. Crispr is developing "revolutionary" CRISPR/Cas-9 technology as a new therapeutic modality with broad ranging applicability, Tenthoff tells investors in a research note. The Phase I/II studies of CTX-001 in transfusion-dependent beta thalassemia and sickle cell disease will report first-in-man data this year potentially curing patients of disease, adds the analyst.
01/22/19
SBSH
01/22/19
DOWNGRADE
SBSH
Sell
Crispr Therapeutics downgraded to Sell from Neutral at Citi
Citi analyst Yigal Nochomovitz downgraded Crispr Therapeutics to Sell.

TODAY'S FREE FLY STORIES

FDX

FedEx

$181.50

-0.92 (-0.50%)

17:40
03/19/19
03/19
17:40
03/19/19
17:40
Hot Stocks
FedEx CEO Fred Smith says Q3 was a 'challenging quarter' »

Says "we're…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

AMRS

Amyris

$3.88

0.05 (1.31%)

17:31
03/19/19
03/19
17:31
03/19/19
17:31
Hot Stocks
Amyris to delay filing 10-K, may have further financial reporting deficiences »

Amyris was unable to file…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$296.55

-1.105 (-0.37%)

17:22
03/19/19
03/19
17:22
03/19/19
17:22
Hot Stocks
Lockheed Martin awarded $264.66M contract modification for Korea F-35 program »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

QHC

Quorum Health

$1.89

-0.02 (-1.05%)

17:20
03/19/19
03/19
17:20
03/19/19
17:20
Hot Stocks
York Capital reports 8.18% passive stake in Quorum Health »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

UPS

UPS

$110.37

-0.31 (-0.28%)

, FDX

FedEx

$181.50

-0.92 (-0.50%)

17:19
03/19/19
03/19
17:19
03/19/19
17:19
Hot Stocks
UPS falls after peer FedEx reports downbeat Q3 results, cuts FY19 EPS view »

UPS (UPS) is dropping in…

UPS

UPS

$110.37

-0.31 (-0.28%)

FDX

FedEx

$181.50

-0.92 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

  • 25

    Apr

BA

Boeing

$373.87

1.77 (0.48%)

17:19
03/19/19
03/19
17:19
03/19/19
17:19
Hot Stocks
Boeing awarded $326.3M Navy delivery order »

Boeing has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

BAYRY

Bayer

$0.00

(0.00%)

17:17
03/19/19
03/19
17:17
03/19/19
17:17
Periodicals
Bayer to face liability in second phase of Roundup trial, Bloomberg says »

Bayer has lost the first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

GD

General Dynamics

$170.72

-1.01 (-0.59%)

17:17
03/19/19
03/19
17:17
03/19/19
17:17
Hot Stocks
General Dynamics' Electric Boat awarded $2B contract modification »

The U.S. Navy has awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

DIS

Disney

$109.97

-3.1 (-2.74%)

, TFCFA

21st Century Fox

$49.62

(0.00%)

17:14
03/19/19
03/19
17:14
03/19/19
17:14
Hot Stocks
Disney, 21st Century Fox say per share value of merger $51.572626 »

The Walt Disney Company…

DIS

Disney

$109.97

-3.1 (-2.74%)

TFCFA

21st Century Fox

$49.62

(0.00%)

TFCF

21st Century Fox

$49.61

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

MOR

MorphoSys

$23.55

-0.165 (-0.70%)

17:13
03/19/19
03/19
17:13
03/19/19
17:13
Hot Stocks
MorphoSys, I-Mab Biopharma initiate phase 2 study of TJ202 for multiple myeloma »

China-based I-Mab…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 08

    May

ARE

Alexandria Real Estate

$139.70

-0.43 (-0.31%)

17:09
03/19/19
03/19
17:09
03/19/19
17:09
Hot Stocks
Alexandria Real Estate co-CEO sells 3,721 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

XXII

22nd Century

$1.94

0.02 (1.04%)

17:02
03/19/19
03/19
17:02
03/19/19
17:02
Hot Stocks
BlackRock reports 6.5% passive stake in 22nd Century »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZTS

Zoetis

$98.72

0.95 (0.97%)

17:00
03/19/19
03/19
17:00
03/19/19
17:00
Initiation
Zoetis initiated at SunTrust »

Zoetis initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDM

Piedmont Office Realty

$20.21

-0.27 (-1.32%)

16:59
03/19/19
03/19
16:59
03/19/19
16:59
Hot Stocks
Piedmont Office Realty CEO Miller to retire, Brent smith to succeed »

Piedmont Office Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 22

    Mar

  • 15

    May

TEVA

Teva

$16.91

0.27 (1.62%)

16:56
03/19/19
03/19
16:56
03/19/19
16:56
Initiation
Teva initiated at SunTrust »

Teva initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

FLIC

First Long Island

$22.35

-0.52 (-2.27%)

16:56
03/19/19
03/19
16:56
03/19/19
16:56
Hot Stocks
First Long Island selects Christopher Becker to succeed Michael Vittorio as CEO »

The First of Long Island…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:51
03/19/19
03/19
16:51
03/19/19
16:51
Hot Stocks
Steelcase boosts quarterly dividend 7% to 14.5c per share »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

PRGO

Perrigo

$49.20

0.52 (1.07%)

16:50
03/19/19
03/19
16:50
03/19/19
16:50
Initiation
Perrigo initiated at SunTrust »

Perrigo initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRMK

Trustmark

$34.42

-0.7 (-1.99%)

16:50
03/19/19
03/19
16:50
03/19/19
16:50
Downgrade
Trustmark rating change at Keefe Bruyette »

Trustmark downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

WIX

Wix.com

$108.92

1.02 (0.95%)

16:49
03/19/19
03/19
16:49
03/19/19
16:49
Initiation
Wix.com initiated at Guggenheim »

Wix.com initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CG

Carlyle Group

$19.00

-0.23 (-1.20%)

16:49
03/19/19
03/19
16:49
03/19/19
16:49
Hot Stocks
Carlyle Group appoints Christopher Finn COO »

Carlyle Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INVH

Invitation Homes

$23.31

-0.23 (-0.98%)

16:49
03/19/19
03/19
16:49
03/19/19
16:49
Syndicate
Invitation Homes files to sell 43M shares of common stock for holders »

Morgan Stanley & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:49
03/19/19
03/19
16:49
03/19/19
16:49
Earnings
Steelcase sees FY20 EPS $1.20-$1.35, consensus $1.32 »

Sees FY20 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

BA

Boeing

$373.87

1.77 (0.48%)

16:48
03/19/19
03/19
16:48
03/19/19
16:48
Periodicals
Boeing CEO says understands 'lives depend' on jet safety, Reuters says »

Boeing CEO Dennis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:47
03/19/19
03/19
16:47
03/19/19
16:47
Earnings
Steelcase sees Q1 EPS 16c-20c, consensus 20c »

Sees Q1 revenue $830 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.